Perfil del autor: López Cortés, Luis Fernando
Datos institucionales
| Nombre | López Cortés, Luis Fernando |
| Departamento | Medicina |
| Área de conocimiento | Medicina |
| Categoría profesional | Profesor Asociado CIS |
| Correo electrónico | Solicitar |
 |
|
Estadísticas
-
Nº publicaciones
27
-
Nº visitas
2404
-
Nº descargas
2624
| Publicaciones |
|---|
Tesis Doctoral
 Intervenciones para disminuir la inflamación y conseguir la remisión virológica persistente en personas que viven con el VIH
(2022)
En la actualidad las personas que viven con VIH-1 o SIDA (PVVS) tienen a su disposición tratamientos antirretrovirales ... |
Artículo
Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Postswitch to Dolutegravir and Rilpivirine in SWORD-1/SWORD-2
(Lippincott, Williams & Wilkins, 2022)
Background: Switching to the 2-drug regimen dolutegravir + rilpivirine demonstrated noninferiority vs continuing a 3-drug ... |
Artículo
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
(Public Library of Science, 2022)
Background The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its ... |
Tesis Doctoral
Activación inmune, inflamación y recuperación inmunológica en distintos escenarios de la infección por el VIH
(2022)
Esta tesis doctoral explora la activación inmunológica e inflamación crónica (AI/Ic) en distintos escenarios de la infección ... |
Artículo
Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV
(FRONTIERS MEDIA SA, 2022)
The initiation of antiretroviral treatment based on a 2-drug regimen (2DR) with dolutegravir plus lamivudine has demonstrated ... |
Artículo
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people
(Journal of clinical investigation, 2022)
The immune factors associated with impaired SARS-CoV-2 vaccine response in elderly people are mostly unknown. We studied ... |
Artículo
Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial
(Wiley-Blackwell, 2022)
Objectives: To evaluate whether simplification of antiretroviral treatment to dual therapy (DT) negatively impacts immune ... |
Artículo
Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non‑late presenters: results from a multicentre cohort study, 2004–2018
(Biomed Central LTD, 2022)
Background: To study whether the association between the CD4/CD8 ratio variation over time and the develop‑ ment of clinical ... |
Artículo
Late presentation for HIV remains a major health issue in Spain: results from a multicenter cohort study, 2004–2018
(Public Library of Science, 2021)
Objectives: With the purpose of reducing the well-known negative impact of late presentation (LP) on people living with ... |
Artículo
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome
(NATURE PUBLISHING GROUP, 2021)
The aim was to assess the ability of nasopharyngeal SARS-CoV-2 viral load at frst patient’s hospital evaluation to predict ... |
Artículo
COVID-19 in hospitalized HIV-positive and HIV-negative patients: a matched study
(Wiley, 2021)
Objectives: We compared the characteristics and clinical outcomes of hospitalized individuals with COVID-19 with [people ... |
Artículo
Mesenchymal stromal cells in human immunodeficiency virus infected patients with discordant immune response: Early results of a phase I/II clinical trial
(Wiley, 2021)
Between 15% and 30% of HIV-infected subjects fail to increase their CD4+ T-cell counts despite continuous viral suppression ... |
Artículo
Enterococcus faecalis Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives
(MDPI, 2020)
The selection of the best alternative for Enterococcus faecalis infective endocarditis (IE) continuation treatment in the ... |
Artículo
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?
(Oxford University Press, 2020)
Background. High uptake of antiretroviral treatment (ART) is essential to reduce human immunodeficiency virus (HIV) ... |
Artículo
Virological outcome among HiV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
(Nature Publishing Group, 2020)
The aim of this transversal study was to describe the virological and immunological features of HIV-infected youths ... |
Artículo
 High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance
(Elsevier, 2019)
To determine the required learning time for high-resolution anoscopy (HRA)-guided biopsy to detect histological high-risk ... |
Artículo
No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients
(Public Library of Science, 2018)
Background Simplification strategies of antiretroviral treatment represent effective tools for the reduction of drug-induced ... |
Ponencia
Population pharmacokinetics of colistin: implications for clinical use for Gram-negative pathogens
(2016)
The objective of this study was to characterize the pharmacokinetics of colistin methanesulphonate (CMS) and colistin in ... |
Artículo
Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients
(Public Library of Science, 2014)
Objective: To establish the role of liver fibrosis as a predictive tool of response to pegylated interferon alpha (Peg-IFN) ... |
Artículo
Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population
(Public Library of Science, 2014)
Etravirine (ETV) is recommended in combination with a boosted protease inhibitor plus an optimized background regimen for ... |
Tesis Doctoral
Concentraciones plasmáticas de Peginterferón-a 2a y Ribavirina y polimorfismo de la IL-28B en la cinética viral y respuesta al tratamiento de la hepatopatía crónica por virus C en pacientes coinfectados por VIH y VHC genotipos 1-4
(2013)
Justificación del estudio. Las concentraciones plasmáticas, tanto de interferón pegilado-alfa (PegIFN-alfa) como ribavirina ... |
Otros
Atazanavir-Based Therapy Is Associated with Higher Hepatitis C Viral Load in HIV Type 1-Infected Subjects with Untreated Hepatitis C
(2013)
We assessed the relationship between atazanavir (ATV)-based antiretroviral treatment (ART) and plasma hepatitis C virus ... |
Artículo
Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
(Public Library of Science, 2012)
Background: The aim of the study was to analyze the different impact of standard and low-dose Peg-IFN-a2a/RBV therapies on ... |
| Artículo |
Artículo
Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits
(American Society for Microbiology, 2000)
Retinal, vitreous humor, brain, and cerebrospinal fluid (CSF) foscarnet levels were measured by high-performance liquid ... |
| Tesis Doctoral |
| Tesis Doctoral |